Prenatal Screening Products and Assays
B·R·A·H·M·S biomarkers provide an outstanding long-term lot-to-lot stability and highest precision Ref-1 for most reliable results in prenatal screening. With our biomarker portfolio we are providing solutions from first trimester trisomy and pre-eclampsia as well as second trimester trisomy and neural tube defect screening to an improved diagnosis and prognosis of pre-eclampsia from 20 weeks until term.
Our prenatal screening products portfolio
B·R·A·H·M·S sFlt-1 KRYPTOR
Optimal patient management: Improved pre-eclampsia diagnosis and prognosis of adverse outcome >
B·R·A·H·M·S PlGF plus KRYPTOR
Optimal patient care in first trimester: Screening for pre-eclampsia and trisomy 21 at once >
B·R·A·H·M·S Fast Screen pre I plus
A modern, powerful, and robust clinical prenatal screening software for first and second trimester >
B·R·A·H·M·S uE3 KRYPTOR
Expansion to second trimester – Screening for trisomy 21 with the Gold Standard >
References Prenatal Screening Products and Assays
Ref-1: Monthly UK NEQAS reports, February 2003 - November 2021.